{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:19:02Z","timestamp":1793319542779,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11054-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:49:03Z","timestamp":1779176943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Host\u2013Microbiota Metabolic Interactions in Atherosclerosis: Oral, gut, and Blood Perspectives"],"prefix":"10.1007","author":[{"given":"Ikram","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Sher","family":"Bacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"11054_CR1","doi-asserted-by":"crossref","unstructured":"Adebayo O, Adeoye AM (2020) Atherosclerosis: a journey around the terminology, in Atherosclerosis, Arteriosclerosis and Arteriolosclerosis, IntechOpen","DOI":"10.5772\/intechopen.91064"},{"issue":"9","key":"11054_CR2","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.3390\/ijms24097910","volume":"24","author":"E Gusev","year":"2023","unstructured":"Gusev E, Sarapultsev A (2023) Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci 24(9):7910","journal-title":"Int J Mol Sci"},{"issue":"14","key":"11054_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","volume":"389","author":"GCR Consortium","year":"2023","unstructured":"Consortium GCR (2023) Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med 389(14):1273\u20131285","journal-title":"N Engl J Med"},{"key":"11054_CR4","first-page":"321","volume":"13","author":"S Alam","year":"2024","unstructured":"Alam S, Aijaz M (2024) Complications of cardiovascular disease: The Impact of diabetes, dyslipidemia, and metabolic disorders. World J Pharm Res 13:321\u2013356","journal-title":"World J Pharm Res"},{"issue":"11","key":"11054_CR5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/biom14111463","volume":"14","author":"Z Li","year":"2024","unstructured":"Li Z, He X, Fang Q, Yin X (2024) Gut microbe-generated metabolite trimethylamine-N-oxide and ischemic stroke. Biomolecules 14(11):1463","journal-title":"Biomolecules"},{"issue":"1","key":"11054_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-025-03878-9","volume":"25","author":"I Khan","year":"2025","unstructured":"Khan I et al (2025) Insights into the blood, gut, and oral microbiomes in Chinese patients with myocardial infarction: a case-control study. BMC Microbiol 25(1):1\u201320","journal-title":"BMC Microbiol"},{"key":"11054_CR7","doi-asserted-by":"publisher","first-page":"1506382","DOI":"10.3389\/fcimb.2025.1506382","volume":"15","author":"S Lei","year":"2025","unstructured":"Lei S et al (2025) Distinct blood and oral microbiome profiles reveal altered microbial composition and functional pathways in myocardial infarction patients. Front Cell Infect Microbiol 15:1506382","journal-title":"Front Cell Infect Microbiol"},{"key":"11054_CR8","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","volume":"14","author":"J Zhen","year":"2023","unstructured":"Zhen J et al (2023) The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front Endocrinol (Lausanne) 14:1085041","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"11054_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/joim.12476","volume":"280","author":"C Slocum","year":"2016","unstructured":"Slocum C, Kramer C, Genco CA (2016) Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis. J Intern Med 280(1):114\u2013128","journal-title":"J Intern Med"},{"key":"11054_CR10","doi-asserted-by":"crossref","unstructured":"Shelat P, Rawal R (2025) Role of metabolomics in uncovering the mechanistic link between microbiome modulation and host metabolism. J Microbiol Biotechnol food Sci, pp. e12612\u2013e12612. https:\/\/orcid.org\/0009-0007-7151-9554","DOI":"10.55251\/jmbfs.12612"},{"issue":"1","key":"11054_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2021.12.011","volume":"34","author":"X Zheng","year":"2022","unstructured":"Zheng X, Cai X, Hao H (2022) Emerging targetome and signalome landscape of gut microbial metabolites. Cell Metab 34(1):35\u201358","journal-title":"Cell Metab"},{"key":"11054_CR12","doi-asserted-by":"crossref","unstructured":"Yntema T, Koonen D, Nutrients FK (2023) and U. Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases, mdpi.com, 2023","DOI":"10.3390\/nu15081850"},{"issue":"23","key":"11054_CR13","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.3390\/ijms252313190","volume":"25","author":"D-K Vo","year":"2024","unstructured":"Vo D-K, Trinh KTL (2024) Emerging biomarkers in metabolomics: advancements in precision health and disease diagnosis. Int J Mol Sci 25(23):13190","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11054_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","volume":"14","author":"AL Jonsson","year":"2017","unstructured":"Jonsson AL, B\u00e4ckhed F (2017) Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 14(2):79\u201387","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"11054_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41569-022-00825-3","volume":"20","author":"A Tonelli","year":"2023","unstructured":"Tonelli A, Lumngwena EN, Ntusi NAB (2023) The oral microbiome in the pathophysiology of cardiovascular disease. Nat Rev Cardiol 20(6):386\u2013403","journal-title":"Nat Rev Cardiol"},{"key":"11054_CR16","doi-asserted-by":"publisher","unstructured":"Duttaroy AK (2021) Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review. Nutrients 13(1):144. https:\/\/doi.org\/10.3390\/nu13010144","DOI":"10.3390\/nu13010144"},{"key":"11054_CR17","doi-asserted-by":"publisher","unstructured":"Feng B et al (2022) An atlas of the blood virome in healthy individuals, Virus Res., vol. 323, no. October p. 199004, 2023. https:\/\/doi.org\/10.1016\/j.virusres.2022.199004","DOI":"10.1016\/j.virusres.2022.199004"},{"key":"11054_CR18","doi-asserted-by":"crossref","unstructured":"Rajasekaran JJ et al (2024) Oral Microbiome: A Comprehensive Review of its Impact on Oral and Systemic Health","DOI":"10.20944\/preprints202406.1923.v2"},{"key":"11054_CR19","unstructured":"Teughels W, Dhondt R, Dekeyser C, Quirynen M (2024) Biofilm and periodontal microbiology, Newman Carranza\u2019s Clin. Periodontol. 4th South Asia Ed., pp. 98\u2013110"},{"key":"11054_CR20","unstructured":"Patrakka O (2024) Studies on the Bacterial Microbiome in Thrombus Aspirates of Acute Ischemic Stroke Patients. Tampereen Yliopist v\u00e4it\u00f6skirjat, 966"},{"key":"11054_CR21","doi-asserted-by":"crossref","unstructured":"Dumitrescu R, Balean O, Bolchis V, Jumanca D (2025 Oct) A Two-Way street: Oral health and systemic diseases. Oral Health-Systemic Public Health Approaches: Systemic Public Health Approaches 29:3","DOI":"10.5772\/intechopen.1009210"},{"issue":"7","key":"11054_CR22","first-page":"1","volume":"2","author":"Y-L Hung","year":"2017","unstructured":"Hung Y-L, Suzuki K (2017) The pattern recognition receptors and lipopolysaccharides (LPS)-induced systemic inflammation. Int J Res Stud Med Heal Sci 2(7):1\u20137","journal-title":"Int J Res Stud Med Heal Sci"},{"issue":"10","key":"11054_CR23","doi-asserted-by":"publisher","first-page":"e70395","DOI":"10.1002\/mco2.70395","volume":"6","author":"X Zhao","year":"2025","unstructured":"Zhao X et al (2025) Advancements and Challenges in Salivary Metabolomics for Early Detection and Monitoring of Systemic Diseases. MedComm 6(10):e70395","journal-title":"MedComm"},{"key":"11054_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/jcpe.13232","volume":"47","author":"N Donos","year":"2020","unstructured":"Donos N, Calciolari E, Brusselaers N, Goldoni M, Bostanci N, Belibasakis GN (2020) The adjunctive use of host modulators in non-surgical periodontal therapy. A systematic review of randomized, placebo\u2010controlled clinical studies. J Clin Periodontol 47:199\u2013238","journal-title":"J Clin Periodontol"},{"issue":"5","key":"11054_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41579-023-00998-9","volume":"22","author":"K Ratiner","year":"2024","unstructured":"Ratiner K, Ciocan D, Abdeen SK, Elinav E (2024) Utilization of the microbiome in personalized medicine. Nat Rev Microbiol 22(5):291\u2013308","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"11054_CR26","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","volume":"113","author":"EZ Gomaa","year":"2020","unstructured":"Gomaa EZ (2020) Human gut microbiota\/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 113(12):2019\u20132040","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"4","key":"11054_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH (2023) Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol 20(4):341\u2013350","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"11054_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293","journal-title":"Intern Emerg Med"},{"key":"11054_CR29","doi-asserted-by":"publisher","first-page":"1606309","DOI":"10.3389\/fmicb.2025.1606309","volume":"16","author":"D Zhang","year":"2025","unstructured":"Zhang D, He X, Shi Y, Chen X, Yu K, Wang S (2025) Gut microbiota regulate atherosclerosis via the gut-vascular axis: a scoping review of mechanisms and therapeutic interventions. Front Microbiol 16:1606309","journal-title":"Front Microbiol"},{"issue":"3","key":"11054_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/1040841X.2022.2058353","volume":"49","author":"Y Gu","year":"2023","unstructured":"Gu Y et al (2023) Bile acid\u2013gut microbiota crosstalk in irritable bowel syndrome. Crit Rev Microbiol 49(3):350\u2013369","journal-title":"Crit Rev Microbiol"},{"key":"11054_CR31","doi-asserted-by":"crossref","unstructured":"Du S, Feng Z, Wang W, Tian L, Wang Y (2022) A structural equation model linking health literacy, self efficacy and quality of life in adults with coronary heart disease, BMC Cardiovasc. Disord., vol. 22, no. 1, Dec","DOI":"10.1186\/s12872-022-02720-8"},{"issue":"8","key":"11054_CR32","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3390\/biomedicines12081844","volume":"12","author":"S Chang","year":"2024","unstructured":"Chang S, Wang Z, An T (2024) T-cell metabolic reprogramming in atherosclerosis. Biomedicines 12(8):1844","journal-title":"Biomedicines"},{"issue":"5","key":"11054_CR33","doi-asserted-by":"publisher","first-page":"e1009514","DOI":"10.1371\/journal.ppat.1009514","volume":"17","author":"EJ Stevens","year":"2021","unstructured":"Stevens EJ, Bates KA, King KC (2021) Host microbiota can facilitate pathogen infection. PLoS Pathog 17(5):e1009514","journal-title":"PLoS Pathog"},{"issue":"11","key":"11054_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrg.2017.63","volume":"18","author":"AB Hall","year":"2017","unstructured":"Hall AB, Tolonen AC, Xavier RJ (2017) Human genetic variation and the gut microbiome in disease. Nat Rev Genet 18(11):690\u2013699","journal-title":"Nat Rev Genet"},{"issue":"1","key":"11054_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13073-016-0296-x","volume":"8","author":"LS Zhang","year":"2016","unstructured":"Zhang LS, Davies SS (2016) Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med 8(1):46","journal-title":"Genome Med"},{"issue":"2","key":"11054_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41591-022-01688-4","volume":"28","author":"S Fromentin","year":"2022","unstructured":"Fromentin S et al (2022) Microbiome and metabolome features of the cardiometabolic disease spectrum. Nat Med 28(2):303\u2013314","journal-title":"Nat Med"},{"key":"11054_CR37","doi-asserted-by":"crossref","unstructured":"Khan I et al (2022) Analysis of the blood bacterial composition of patients with acute coronary syndrome and chronic coronary syndrome, Front. Cell. Infect. Microbiol., vol. 12, no. October, pp. 1\u201315, Oct","DOI":"10.3389\/fcimb.2022.943808"},{"key":"11054_CR38","doi-asserted-by":"crossref","unstructured":"Khan I et al (2022) Circulating microbiota and metabolites: Insights into cardiovascular diseases, Wiley Online Libr., vol. 36, no. 12, Dec","DOI":"10.1002\/jcla.24779"},{"key":"11054_CR39","doi-asserted-by":"publisher","first-page":"1541085","DOI":"10.3389\/fbrio.2025.1541085","volume":"4","author":"I Khan","year":"2025","unstructured":"Khan I et al (2025) Blood microbiome and cardiometabolic disease: insights, therapeutic strategies, and future directions. Front Bacteriol 4:1541085","journal-title":"Front Bacteriol"},{"key":"11054_CR40","doi-asserted-by":"publisher","first-page":"1616029","DOI":"10.3389\/fcimb.2025.1616029","volume":"15","author":"I Khan","year":"2025","unstructured":"Khan I, Irfan M, Khan I, Noor U, Xie X, Zhiqiang L (2025) Blood microbiome signatures in systemic diseases: current insights, methodological pitfalls, and future horizons. Front Cell Infect Microbiol 15:1616029","journal-title":"Front Cell Infect Microbiol"},{"key":"11054_CR41","doi-asserted-by":"publisher","unstructured":"Khan I, Panaiotov S, Attia KA, Mohammed AA, Uzair M, Khan I (2025) Integrated analysis of blood microbiome and metabolites reveals key biomarkers and functional pathways in myocardial infarction, 3. https:\/\/doi.org\/10.1186\/s12967-025-06165-3","DOI":"10.1186\/s12967-025-06165-3"},{"key":"11054_CR42","doi-asserted-by":"publisher","unstructured":"Khan I et al (2022) Exploring blood microbial communities and their influence on human cardiovascular disease. no. March, pp. 1\u201311. https:\/\/doi.org\/10.1002\/jcla.24354","DOI":"10.1002\/jcla.24354"},{"issue":"2","key":"11054_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS (2019) Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol 27(2):105\u2013117","journal-title":"Trends Microbiol"},{"issue":"6","key":"11054_CR44","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.3390\/ijms24065633","volume":"24","author":"HS Cheng","year":"2023","unstructured":"Cheng HS, Tan SP, Wong DM, Koo WL, Wong SH, Tan NS (2023) The blood microbiome and health: current evidence, controversies, and challenges. Int J Mol Sci 24(6):5633","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11054_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrmicro.2016.12","volume":"14","author":"AJ Olive","year":"2016","unstructured":"Olive AJ, Sassetti CM (2016) Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microbiol 14(4):221\u2013234","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"11054_CR46","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3390\/ijms19103228","volume":"19","author":"M Canyelles","year":"2018","unstructured":"Canyelles M, Tondo M, Ced\u00f3 L, Farr\u00e0s M, Escol\u00e0-Gil JC, Blanco-Vaca F (2018) Trimethylamine N-oxide: a link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function. Int J Mol Sci 19(10):3228","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11054_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/1753425915606525","volume":"21","author":"S Khakpour","year":"2015","unstructured":"Khakpour S, Wilhelmsen K, Hellman J (2015) Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun 21(8):827\u2013846","journal-title":"Innate Immun"},{"issue":"44","key":"11054_CR48","doi-asserted-by":"publisher","first-page":"16498","DOI":"10.3748\/wjg.v20.i44.16498","volume":"20","author":"CWY Ha","year":"2014","unstructured":"Ha CWY, Lam YY, Holmes AJ (2014) Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol WJG 20(44):16498","journal-title":"World J Gastroenterol WJG"},{"key":"11054_CR49","doi-asserted-by":"publisher","first-page":"845942","DOI":"10.3389\/fcvm.2022.845942","volume":"9","author":"Y Gui","year":"2022","unstructured":"Gui Y, Zheng H, Cao RY (2022) Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms. Front Cardiovasc Med 9:845942","journal-title":"Front Cardiovasc Med"},{"key":"11054_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-021-00910-x","volume":"23","author":"MS Thomas","year":"2021","unstructured":"Thomas MS, Fernandez ML (2021) Trimethylamine N-oxide (TMAO), diet and cardiovascular disease. Curr Atheroscler Rep 23:1\u20137","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"11054_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13765-022-00755-1","volume":"66","author":"V Vu","year":"2023","unstructured":"Vu V, Kim YM, Cho M (2023) Effects of SCFAs and TMAO on non-alcoholic fatty liver disease indicating the therapeutic benefits of plant-based diet, and supplemental prebiotics, probiotics and synbiotics. Appl Biol Chem 66(1):11","journal-title":"Appl Biol Chem"},{"issue":"7","key":"11054_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","volume":"19","author":"CD Fuchs","year":"2022","unstructured":"Fuchs CD, Trauner M (2022) Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol 19(7):432\u2013450","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"11054_CR53","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/gutjnl-2020-323263","volume":"70","author":"K Xu","year":"2021","unstructured":"Xu K et al (2021) Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn. Gut 70(8):1486\u20131494","journal-title":"Gut"},{"key":"11054_CR54","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.abb.2019.07.022","volume":"672","author":"H Yoshida","year":"2019","unstructured":"Yoshida H, Ishii M, Akagawa M (2019) Propionate suppresses hepatic gluconeogenesis via GPR43\/AMPK signaling pathway. Arch Biochem Biophys 672:108057","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"11054_CR55","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/1389203716666150630135720","volume":"16","author":"J Chen","year":"2015","unstructured":"Chen J et al (2015) Interaction between microbes and host intestinal health: modulation by dietary nutrients and gut-brain-endocrine-immune axis. Curr Protein Pept Sci 16(7):592\u2013603","journal-title":"Curr Protein Pept Sci"},{"issue":"10","key":"11054_CR56","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/17460441.2019.1638909","volume":"14","author":"Y Du","year":"2019","unstructured":"Du Y, Li X, Su C, Wang L, Jiang J, Hong B (2019) The human gut microbiome\u2013a new and exciting avenue in cardiovascular drug discovery. Expert Opin Drug Discov 14(10):1037\u20131052","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"11054_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s10020-021-00407-y","volume":"27","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen W-D, Wang Y-D (2021) Nuclear receptors: a bridge linking the gut microbiome and the host. Mol Med 27(1):144","journal-title":"Mol Med"},{"issue":"1","key":"11054_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13105-023-00984-y","volume":"80","author":"Z Luo","year":"2024","unstructured":"Luo Z, Yu X, Wang C, Zhao H, Wang X, Guan X (2024) Trimethylamine N-oxide promotes oxidative stress and lipid accumulation in macrophage foam cells via the Nrf2\/ABCA1 pathway. J Physiol Biochem 80(1):67\u201379","journal-title":"J Physiol Biochem"},{"issue":"14","key":"11054_CR59","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.3390\/jcm13144258","volume":"13","author":"J Nuszkiewicz","year":"2024","unstructured":"Nuszkiewicz J et al (2024) Intersecting pathways: the role of metabolic dysregulation, gastrointestinal microbiome, and inflammation in acute ischemic stroke pathogenesis and outcomes. J Clin Med 13(14):4258","journal-title":"J Clin Med"},{"issue":"1","key":"11054_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000356211","volume":"89","author":"I Kaji","year":"2014","unstructured":"Kaji I, Karaki S, Kuwahara A (2014) Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion 89(1):31\u201336","journal-title":"Digestion"},{"key":"11054_CR61","doi-asserted-by":"publisher","first-page":"594150","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2021","unstructured":"Mohammad S, Thiemermann C (2021) Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol 11:594150","journal-title":"Front Immunol"},{"issue":"3","key":"11054_CR62","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00018-020-03645-1","volume":"78","author":"J-R Liu","year":"2021","unstructured":"Liu J-R, Miao H, Deng D-Q, Vaziri ND, Li P, Zhao Y-Y (2021) Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cell Mol Life Sci 78(3):909\u2013922","journal-title":"Cell Mol Life Sci"},{"key":"11054_CR63","doi-asserted-by":"publisher","unstructured":"Carloni S, Strati F (2025) The Gut Vascular Barrier: Linking the Intestinal Environment with Blood Circulation. Physical and Biological Barriers at the Interface Between the Gut Microbiome and the Immune System. Springer, pp 57\u201374. https:\/\/doi.org\/10.1007\/978-3-031-84065-4_4","DOI":"10.1007\/978-3-031-84065-4_4"},{"issue":"1","key":"11054_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/molecules26010179","volume":"26","author":"S Eshghjoo","year":"2021","unstructured":"Eshghjoo S, Jayaraman A, Sun Y, Alaniz RC (2021) Microbiota-mediated immune regulation in atherosclerosis. Molecules 26(1):179","journal-title":"Molecules"},{"key":"11054_CR65","doi-asserted-by":"publisher","first-page":"1001275","DOI":"10.37349\/emed.2025.1001275","volume":"6","author":"A Vargas","year":"2025","unstructured":"Vargas A et al (2025) Gut microbiota-derived metabolites and chronic inflammatory diseases. Explor Med 6:1001275","journal-title":"Explor Med"},{"issue":"8","key":"11054_CR66","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/ijms22083850","volume":"22","author":"DJ Medina-Leyte","year":"2021","unstructured":"Medina-Leyte DJ, Zepeda-Garc\u00eda O, Dom\u00ednguez-P\u00e9rez M, Gonz\u00e1lez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L (2021) Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci 22(8):3850","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11054_CR67","doi-asserted-by":"publisher","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","volume":"4","author":"SS Ghosh","year":"2020","unstructured":"Ghosh SS, Wang J, Yannie PJ, Ghosh S (2020) Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocr Soc 4(2):bvz039","journal-title":"J Endocr Soc"},{"issue":"22","key":"11054_CR68","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1021\/acs.jafc.9b01270","volume":"67","author":"G Yang","year":"2019","unstructured":"Yang G et al (2019) Nobiletin prevents trimethylamine oxide-induced vascular inflammation via inhibition of the NF-\u03baB\/MAPK pathways. J Agric Food Chem 67(22):6169\u20136176","journal-title":"J Agric Food Chem"},{"key":"11054_CR69","doi-asserted-by":"publisher","first-page":"1250263","DOI":"10.3389\/fcvm.2023.1250263","volume":"10","author":"DF Gualtero","year":"2023","unstructured":"Gualtero DF, Lafaurie GI, Buitrago DM, Castillo Y, Vargas-Sanchez PK, Castillo DM (2023) Oral microbiome mediated inflammation, a potential inductor of vascular diseases: a comprehensive review. Front Cardiovasc Med 10:1250263","journal-title":"Front Cardiovasc Med"},{"key":"11054_CR70","doi-asserted-by":"publisher","first-page":"1103592","DOI":"10.3389\/fimmu.2023.1103592","volume":"14","author":"Q Ruan","year":"2023","unstructured":"Ruan Q et al (2023) Porphyromonas gingivalis regulates atherosclerosis through an immune pathway. Front Immunol 14:1103592","journal-title":"Front Immunol"},{"issue":"10","key":"11054_CR71","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/pathogens10101280","volume":"10","author":"D Celik","year":"2021","unstructured":"Celik D, Kantarci A (2021) Vascular changes and hypoxia in periodontal disease as a link to systemic complications. Pathogens 10(10):1280","journal-title":"Pathogens"},{"issue":"1","key":"11054_CR72","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran AC (2022) Inflammation resolution: implications for atherosclerosis. Circ Res 130(1):130\u2013148","journal-title":"Circ Res"},{"issue":"8","key":"11054_CR73","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH (2024) Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 24(8):577\u2013595","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"11054_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000484623","volume":"44","author":"KM Boini","year":"2018","unstructured":"Boini KM, Hussain T, Li P-L, Koka SS (2018) Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction. Cell Physiol Biochem 44(1):152\u2013162","journal-title":"Cell Physiol Biochem"},{"key":"11054_CR75","first-page":"175628482311764","volume":"16","author":"L-Z Shu","year":"2023","unstructured":"Shu L-Z, Ding Y-D, Xue Q-M, Cai W, Deng H (2023) Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier. Th Adv Gastroenterol 16:17562848231176428","journal-title":"Th Adv Gastroenterol"},{"issue":"4","key":"11054_CR76","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/femsre\/fuv013","volume":"39","author":"M Potgieter","year":"2015","unstructured":"Potgieter M, Bester J, Kell DB, Pretorius E (2015) The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev 39(4):567\u2013591. https:\/\/doi.org\/10.1093\/femsre\/fuv013","journal-title":"FEMS Microbiol Rev"},{"key":"11054_CR77","doi-asserted-by":"publisher","first-page":"657344","DOI":"10.3389\/fimmu.2021.657344","volume":"12","author":"R Amadio","year":"2021","unstructured":"Amadio R, Piperno GM, Benvenuti F (2021) Self-DNA sensing by cGAS-STING and TLR9 in autoimmunity: is the cytoskeleton in control? Front Immunol 12:657344","journal-title":"Front Immunol"},{"issue":"12","key":"11054_CR78","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.3390\/app15126847","volume":"15","author":"BM Messina","year":"2025","unstructured":"Messina BM, Grippaudo C, Polizzi A, Blasi A, Isola G (2025) The Key Role of Porphyromonas gingivalis in the Pathogenesis of Periodontitis Linked with Systemic Diseases. Appl Sci 15(12):6847","journal-title":"Appl Sci"},{"issue":"17","key":"11054_CR79","doi-asserted-by":"publisher","first-page":"8488","DOI":"10.3390\/ijms26178488","volume":"26","author":"A-K Tonch-Cerbu","year":"2025","unstructured":"Tonch-Cerbu A-K, Boicean A-G, Stoia O-M, Teodoru M (2025) Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets. Int J Mol Sci 26(17):8488","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11054_CR80","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nri.2017.25","volume":"17","author":"KJ Kieser","year":"2017","unstructured":"Kieser KJ, Kagan JC (2017) Multi-receptor detection of individual bacterial products by the innate immune system. Nat Rev Immunol 17(6):376\u2013390","journal-title":"Nat Rev Immunol"},{"key":"11054_CR81","doi-asserted-by":"crossref","unstructured":"Shmeleva EV, Levin M (2025) The Hijacker\u2019s Guide to biological systems: Manipulation by self-defecting or foreign agents","DOI":"10.31219\/osf.io\/behxt_v1"},{"key":"11054_CR82","doi-asserted-by":"publisher","first-page":"693479","DOI":"10.3389\/fimmu.2021.693479","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Multifaceted impacts of periodontal pathogens in disorders of the intestinal barrier. Front Immunol 12:693479","journal-title":"Front Immunol"},{"issue":"4","key":"11054_CR83","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/microorganisms13040814","volume":"13","author":"NA Adil","year":"2025","unstructured":"Adil NA, Omo-Erigbe C, Yadav H, Jain S (2025) The oral\u2013gut microbiome\u2013brain axis in cognition. Microorganisms 13(4):814","journal-title":"Microorganisms"},{"key":"11054_CR84","doi-asserted-by":"publisher","first-page":"1132420","DOI":"10.3389\/fcimb.2023.1132420","volume":"13","author":"T Zhou","year":"2023","unstructured":"Zhou T et al (2023) The effect of the \u2018Oral-Gut\u2019 axis on periodontitis in inflammatory bowel disease: A review of microbe and immune mechanism associations. Front Cell Infect Microbiol 13:1132420","journal-title":"Front Cell Infect Microbiol"},{"issue":"22","key":"11054_CR85","doi-asserted-by":"publisher","first-page":"12337","DOI":"10.3390\/ijms252212337","volume":"25","author":"Z Wang","year":"2024","unstructured":"Wang Z, Kaplan RC, Burk RD, Qi Q (2024) The oral microbiota, microbial metabolites, and immuno-inflammatory mechanisms in cardiovascular disease. Int J Mol Sci 25(22):12337","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11054_CR86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","volume":"20","author":"F Violi","year":"2023","unstructured":"Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C (2023) Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol 20(1):24\u201337","journal-title":"Nat Rev Cardiol"},{"key":"11054_CR87","doi-asserted-by":"crossref","unstructured":"Suchiita A, Gupta N, Nandi K, Sonkar S, Chandra L (2025) Harmony within: unravelling the microbiome\u2013immune system symbiosis for health, Adv. Gut Microbiome Res., vol. no. 1, p. 9927379, 2025","DOI":"10.1155\/agm3\/9927379"},{"key":"11054_CR88","doi-asserted-by":"crossref","unstructured":"Aarabi G, Heydecke G, Seedorf U (1978) Roles of oral infections in the pathomechanism of atherosclerosis, Int. J. Mol. Sci., vol. 19, no. 7, p. 2018","DOI":"10.3390\/ijms19071978"},{"issue":"20","key":"11054_CR89","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3390\/nu15204466","volume":"15","author":"Y Shin","year":"2023","unstructured":"Shin Y et al (2023) Roles of short-chain fatty acids in inflammatory bowel disease. Nutrients 15(20):4466","journal-title":"Nutrients"},{"issue":"6","key":"11054_CR90","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16(6):341\u2013352","journal-title":"Nat Rev Immunol"},{"key":"11054_CR91","doi-asserted-by":"crossref","unstructured":"Mahajan G, Acharjee S, Gupta S, Bhardwaj H, Gupta R (2025) Role of Oral Bacteria in Cardiac Diseases. in Oral Microbiome. CRC, pp 231\u2013256","DOI":"10.1201\/9781003478638-13"},{"issue":"3","key":"11054_CR92","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/ijms26031379","volume":"26","author":"\u015eH Ro\u015fian","year":"2025","unstructured":"Ro\u015fian \u015eH, Boarescu I, Boarescu P-M (2025) Antioxidant and anti-inflammatory effects of bioactive compounds in atherosclerosis. Int J Mol Sci 26(3):1379","journal-title":"Int J Mol Sci"},{"issue":"23","key":"11054_CR93","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.3390\/ijms252312511","volume":"25","author":"K Jaworska","year":"2024","unstructured":"Jaworska K, Kopacz W, Koper M, Ufnal M (2024) Microbiome-derived trimethylamine N-oxide (TMAO) as a multifaceted biomarker in cardiovascular disease: challenges and opportunities. Int J Mol Sci 25(23):12511","journal-title":"Int J Mol Sci"},{"key":"11054_CR94","doi-asserted-by":"crossref","unstructured":"Beliz\u00e1rio JE, Faintuch J, Garay-Malpartida M (2018) Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases, Mediators Inflamm., vol. no. 1, p. 2037838, 2018","DOI":"10.1155\/2018\/2037838"},{"issue":"1","key":"11054_CR95","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3934\/microbiol.2018.1.42","volume":"4","author":"N Sharma","year":"2018","unstructured":"Sharma N, Bhatia S, Sodhi AS, Batra N (2018) Oral microbiome and health. AIMS Microbiol 4(1):42","journal-title":"AIMS Microbiol"},{"issue":"3","key":"11054_CR96","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/microorganisms9030496","volume":"9","author":"B Khor","year":"2021","unstructured":"Khor B et al (2021) Interconnections between the oral and gut microbiomes: reversal of microbial dysbiosis and the balance between systemic health and disease. Microorganisms 9(3):496","journal-title":"Microorganisms"},{"issue":"3","key":"11054_CR97","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000447252","volume":"1","author":"H Fukui","year":"2016","unstructured":"Fukui H (2016) Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis 1(3):135\u2013145","journal-title":"Inflamm Intest Dis"},{"issue":"1","key":"11054_CR98","doi-asserted-by":"publisher","first-page":"pp107","DOI":"10.1111\/prd.12393","volume":"87","author":"L Sedghi","year":"2021","unstructured":"Sedghi L, DiMassa V, Harrington A, Lynch SV, Kapila YL (2021) The oral microbiome: Role of key organisms and complex networks in oral health and disease. Periodontol 2000 87(1):pp107\u2013131","journal-title":"Periodontol 2000"},{"issue":"3","key":"11054_CR99","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.3390\/ijms24032399","volume":"24","author":"R El Hage","year":"2023","unstructured":"El Hage R, Al-Arawe N, Hinterseher I (2023) The role of the gut microbiome and trimethylamine oxide in atherosclerosis and age-related disease. Int J Mol Sci 24(3):2399","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11054_CR100","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.3390\/ijms26083621","volume":"26","author":"P Ioannou","year":"2025","unstructured":"Ioannou P, Katsoulieris E, Afratis NA (2025) Matrix Dynamics and Microbiome Crosstalk: Matrix Metalloproteinases as Key Players in Disease and Therapy. Int J Mol Sci 26(8):3621","journal-title":"Int J Mol Sci"},{"key":"11054_CR101","doi-asserted-by":"publisher","first-page":"797046","DOI":"10.3389\/fcvm.2021.797046","volume":"8","author":"T Gerhardt","year":"2022","unstructured":"Gerhardt T, Haghikia A, Stapmanns P, Leistner DM (2022) Immune mechanisms of plaque instability. Front Cardiovasc Med 8:797046","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"11054_CR102","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/odi.12472","volume":"22","author":"TA van der Meulen","year":"2016","unstructured":"van der Meulen TA, Harmsen HJM, Bootsma H, Spijkervet FKL, Kroese FGM, Vissink A (2016) The microbiome\u2013systemic diseases connection. Oral Dis 22(8):719\u2013734","journal-title":"Oral Dis"},{"issue":"4","key":"11054_CR103","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/ph16040504","volume":"16","author":"M Shanmugham","year":"2023","unstructured":"Shanmugham M, Bellanger S, Leo CH (2023) Gut-derived metabolite, trimethylamine-N-oxide (TMAO) in cardio-metabolic diseases: detection, mechanism, and potential therapeutics. Pharmaceuticals 16(4):504","journal-title":"Pharmaceuticals"},{"issue":"10","key":"11054_CR104","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/nu10101398","volume":"10","author":"MH Janeiro","year":"2018","unstructured":"Janeiro MH, Ram\u00edrez MJ, Milagro FI, Mart\u00ednez JA, Solas M (2018) Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients 10(10):1398","journal-title":"Nutrients"},{"issue":"11","key":"11054_CR105","doi-asserted-by":"publisher","first-page":"e13316","DOI":"10.1111\/obr.13316","volume":"22","author":"S Zhang","year":"2021","unstructured":"Zhang S et al (2021) Dietary fiber-derived short\u2010chain fatty acids: A potential therapeutic target to alleviate obesity\u2010related nonalcoholic fatty liver disease. Obes Rev 22(11):e13316","journal-title":"Obes Rev"},{"issue":"9","key":"11054_CR106","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/antiox14091049","volume":"14","author":"C-N Hsu","year":"2025","unstructured":"Hsu C-N et al (2025) Antioxidants, Gut Microbiota, and Cardiovascular Programming: Unraveling a Triad of Early-Life Interactions. Antioxidants 14(9):1049","journal-title":"Antioxidants"},{"issue":"2","key":"11054_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","volume":"4","author":"JY Chiang","year":"2020","unstructured":"Chiang JY, Ferrell JM (2020) Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res 4(2):47\u201363","journal-title":"Liver Res"},{"issue":"4","key":"11054_CR108","first-page":"G209","volume":"309","author":"M Camilleri","year":"2015","unstructured":"Camilleri M, Gores GJ (2015) Therapeutic targeting of bile acids. Am J Physiol Liver Physiol 309(4):G209\u2013G215","journal-title":"Am J Physiol Liver Physiol"},{"issue":"16","key":"11054_CR109","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/cells14161237","volume":"14","author":"J Kumar","year":"2025","unstructured":"Kumar J (2025) Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy. Cells 14(16):1237","journal-title":"Cells"},{"key":"11054_CR110","doi-asserted-by":"publisher","first-page":"1434799","DOI":"10.3389\/fmedt.2024.1434799","volume":"6","author":"TC Dakal","year":"2025","unstructured":"Dakal TC, Xu C, Kumar A (2025) Advanced computational tools, artificial intelligence and machine-learning approaches in gut microbiota and biomarker identification. Front Med Technol 6:1434799","journal-title":"Front Med Technol"},{"issue":"6","key":"11054_CR111","doi-asserted-by":"publisher","first-page":"936","DOI":"10.17305\/bb.2023.8893","volume":"23","author":"YH Oktaviono","year":"2023","unstructured":"Oktaviono YH et al (2023) The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review. Biomol Biomed 23(6):936","journal-title":"Biomol Biomed"},{"key":"11054_CR112","doi-asserted-by":"publisher","first-page":"107327482412920","DOI":"10.1177\/10732748241292019","volume":"31","author":"F Luo","year":"2024","unstructured":"Luo F, Wang X, Ye C, Sun H (2024) Microbial biomarkers in liquid biopsy for cancer: an overview and future directions. Cancer Control 31:10732748241292020","journal-title":"Cancer Control"},{"issue":"2","key":"11054_CR113","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","volume":"8","author":"HD Holscher","year":"2017","unstructured":"Holscher HD (2017) Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8(2):172\u2013184","journal-title":"Gut Microbes"},{"issue":"6","key":"11054_CR114","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.ahj.2004.09.059","volume":"149","author":"G Seinost","year":"2005","unstructured":"Seinost G et al (2005) Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 149(6):1050\u20131054","journal-title":"Am Heart J"},{"issue":"1","key":"11054_CR115","doi-asserted-by":"publisher","first-page":"2323237","DOI":"10.1080\/19490976.2024.2323237","volume":"16","author":"B Shi","year":"2024","unstructured":"Shi B, Li H, He X (2024) Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation. Gut Microbes 16(1):2323237","journal-title":"Gut Microbes"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11054-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:02:28Z","timestamp":1779220948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11054-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":115,"alternative-id":["11054"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11054-2","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}